Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
December 4, 2018
Patent Application Number
15446298
Date Filed
March 1, 2017
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present disclosure provides novel macrocyclic compounds which inhibit the PD-1/PD-L1 and PD-L1/CD80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
